NEW YORK (GenomeWeb News) – Atreca today announced it has licensed immune repertoire capture technology from Stanford University, which the biopharmaceutical company will develop for a broad range of applications.

The technology was developed in the laboratories of William Robinson, an associate professor of medicine in the Division of Immunology and Rheumatology at Stanford, and leverages next-generation sequencing to identify new antibodies that have utility themselves and that define targets of functional immune response.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.